82
Views
0
CrossRef citations to date
0
Altmetric
Letter

Letter to the editor: anti-TNF therapy and radiation exposure in Crohn's disease: chicken or egg?

&

References

  • Magro F, Coelho R, Guimaraes LS, et al. Ionizing radiation exposure is still increasing in Crohn's disease: who should be blamed? Scand J Gastroenterol. 2015;50:1214–1225.
  • Levi Z, Fraser E, Krongrad R, et al. Factors associated with radiation exposure in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2009;30:1128–1136.
  • Desmond AN, O'Regan K, Curran C, et al. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008;57:1524–1529.
  • Butcher RO, Nixon E, Sapundzieski M, et al. Radiation exposure in patients with inflammatory bowel disease-primum non nocere? Scand J Gastroenterol. 2012;47:1192–1199.
  • Patil SA, Rustgi A, Quezada SM, et al. Anti-TNF therapy is associated with decreased imaging and radiation exposure in patients with Crohn's disease. Inflamm Bowel Dis. 2013;19:92–98.
  • Aggarwal D, Limdi JK. Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease. Eur J Gastroenterol Hepatol. 2015;27:13–19.
  • Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128:862–869.
  • Loftus EV, Feagan BG, Colombel JF, et al. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol. 2008;103:3132–3141.
  • Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis. 2013;7:556–585.
  • Qiu Y, Mao R, Chen BL, et al. Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease. Aliment Pharmacol Ther. 2014;40:134–146.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.